Pharmerging Market Size Projected to Surpass USD 7.1 Billion by 2034 at an 11.6% CAGR| Report by Transparency Market Research, Inc.
Healthcare infrastructure development and increased funding are likely to drive demand for pharmerging.
Wilmington, Delaware, United States, Transparency Market Research, Inc., Oct. 17, 2024 (GLOBE NEWSWIRE) — The pharmerging market accounted for US$ 2.1 billion in 2023. It is expected to advance at a CAGR of 11.6% from 2024 to 2034 and
Global Pharmerging Market: Competitive Landscape
Pharma and healthcare companies can form strategic partnerships with other companies, research institutions, and healthcare providers to drive innovation, expand market reach, and improve drug discovery, development, and delivery capabilities.
Key Developments
- Abbott Laboratories is a leading product manufacturer of medical devices, generic pharmaceuticals, diagnostics, nutritional products, and branded pharmaceuticals.
- Koninklijke Philips N.V. is an international company that specializes in healthcare, lighting, and consumer products. Aside from healthcare equipment, they offer a variety of services.
- F. Hoffmann-La Roche Ltd. is one of the world’s leading pharmaceutical and diagnostic companies. Innovative treatments are offered in fields such as immunology, oncology, infectious diseases, and others.
Global Pharmerging Market: Segmentation
Product Type
- Pharmaceuticals
- Branded Prescription Drugs
- Generic Drugs
- Branded Generics
- Unbranded Generics
- OTC Drugs
- Healthcare
- Medical Devices
- Diagnostic Instruments
- Others (IT and Record Management)
Indication
- Lifestyle Diseases
- Cancer and Autoimmune Diseases
- Infectious Diseases
- Others
Distribution Channel
- Hospitals
- Clinics
- Retail Pharmacies
- E-commerce
- Drugs Stores
Region
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=8200<ype=S
More Trending Reports by Transparency Market Research –
- Vaccines Market– The global vaccines market is projected to advance at a CAGR of 4.2% from 2023 to 2031.
- Diabetes Devices Market – The global diabetes devices market is projected to expand at a CAGR of 6.0% during the forecast period from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube
